EPI Update, May 10, 2013 by unknown
EPI Update for Friday, May 10, 2013 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
  
Items for this week’s EPI Update include:  
• Discontinuing of virus culture at SHL 
• Consider using azithromycin to treat chlamydia  
• Hepatitis C testing guidance for clinicians and laboratorians updated to 
emphasize RNA testing   
• Tick season has arrived 
• Meeting announcements and training opportunities 
   
Discontinuing of virus culture at SHL 
The State Hygienic Laboratory is discontinuing the performance of the following tests: 
Virus Isolation/Detection and Identification, Chlamydia trachomatis culture, 
Cytomegalovirus culture (CMV), and Respiratory Syncytial Virus (RSV) DFA and 
culture. Friday, June 14, 2013 will be the last day that SHL will accept specimens for 
this testing.  
 
Virus culture is no longer the preferred method for detecting virus for diagnostic or 
surveillance purposes. Molecular methods continue to advance at a rapid rate and are 
replacing virus culture methods for identification and characterization of both known and 
novel viruses.  
 
Testing of lesion and genital swabs for HSV and VZV will continue by DFA, including 
reflexing negative DFAs to culture. For CSF specimens, testing by PCR is appropriate 
for detection of HSV and Enterovirus.   
 
SHL will continue to offer its viral and bacterial PCR menu. If virus culture is needed, 
there are private and commercial laboratories in Iowa that are still currently offering 
culture. For details please visit the SHL website at 
www.shl.uiowa.edu/news/virusculture.xml.   
 
Consider using azithromycin to treat chlamydia  
Doxycycline is a commonly prescribed alternative medication for chlamydial infections. 
A nationwide doxycycline shortage has caused the price of doxycycline to increase 
substantially. Prescribers should be aware of the price increase for doxycycline and 
consider utilizing other recommended treatments, when appropriate. The recommended 
treatment for chlamydia in the 2010 STD Treatment Guidelines is 1 gram of 
azithromycin given orally in a single dose. Clinicians who diagnose cases of chlamydia 
are encouraged to utilize azithromycin instead of doxycycline. Azithromycin is available 
generically, and has not experienced recent price increases. The 2010 STD Treatment 
Guidelines are available at www.cdc.gov/std/treatment/2010/STD-Treatment-2010-
RR5912.pdf.  
 
Hepatitis C testing guidance for clinicians and laboratorians updated to 
emphasize RNA testing   
An estimated 4.1 million persons have been infected with hepatitis C virus (HCV) in the 
United States, most of which are unaware of their infection status. 
 
CDC continues to recommend HCV testing for the following groups:   
• Persons born from 1945 through 1965 (Baby Boomer population) 
• Persons who received blood products with clotting factor before 1987 
• Persons who have received blood transfusion or organ transplant before July 
1992 
• Injection drugs users who have ever shared needles or other equipment, even if 
only one time  
• Persons infected with HIV  
• Persons who have been on kidney dialysis for several years 
• Health or public safety workers who have been stuck with a needle or other 
sharp object with blood from a person with hepatitis C or unknown hepatitis C 
status  
• Infants born to a mother with hepatitis C 
 
CDC has recently updated their HCV testing guidance to emphasize the need to do 
RNA testing to distinguish between current and past infection. Testing for antibody to 
HCV does not distinguish between past infection that has resolved and current infection 
that requires care and evaluation. To identify current infection, a test for HCV RNA is 
critical. 
 
To view the updated testing guidance, visit 
www.cdc.gov/mmwr/preview/mmwrhtml/mm6218a5.htm?s_cid=mm6218a5_w.  
 
For additional information on HCV activity in the U.S., 
visit  www.cdc.gov/mmwr/preview/mmwrhtml/mm6218a4.htm?s_cid=mm6218a4_w.  
 
Tick season has arrived 
Tick season has begun, please encourage patients to take measures to prevent tick 
exposure (such as using DEET).  Several providers have recently asked whether tick 
testing is available.  Iowa State University will accept ticks as part of their Lyme disease 
surveillance program.  Submitters will receive information back on species of the tick 
they submitted but no Lyme disease information will be available.     
 
For more information on tick testing and the address where ticks may be sent, visit 
www.ent.iastate.edu/medent/ticks_IA.  
 
Meeting announcements and training opportunities 
Registration is now open for the 2013 Iowa Immunization Conference, which will take 
place June 12 and 13 at Veterans Memorial Auditorium in Des Moines. For more 
information and to register, visit 
www.idph.state.ia.us/ImmTB/Immunization.aspx?prog=Imm&pg=ImmHome .  
 
The 2013 Annual CSTE Conference will be held June 9 through13 in Pasadena, CA. 
For more information, visit cste.confex.com/cste/2013/late/cfp.cgi . 
 
Dr. Patricia Quinlisk from IDPH and Dr. Lucy Desjardin from SHL will be teaching a 
course titled “Field Experiences in Public Health” this summer. The course is available 
to University of Iowa, Iowa State University, and Des Moines University students who 
have taken a public health epidemiology course. The course will be taught electronically 
from two locations (University of Iowa and Des Moines University).Students will gain 
experience in several areas of public health using practical examples, site visits, and 
field investigations. For more information, call 319-335-2575 or 800-272-6430. 
 
We wish everyone a happy and healthy week! 
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